ReviewHistochemistry and cell biology2026
A brief history of the human liver peroxisome.
Review in Histochemistry and cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human liver peroxisome deserves a special review because it differs from peroxisomes in laboratory animals and cultured cells. We provide an overview of the historical stepping stones, with special emphasis on electron microscopy, enzyme- and immunocytochemistry, and morphometry. The contributions from several hundreds of patients, children with inherited diseases and adults with acquired illnesses are summarized. Intriguing findings such as liver peroxisomes of a patient changing over time, or the patient series with peroxisome mosaics in the liver, are highlighted. We compare our own data with the more recent discoveries, in particular the endoplasmic reticulum-peroxisome membrane contact sites and their inherited deficiencies: retinal dystrophy with leukodystrophy (RDLD). For complete diagnosis, expanded phenotyping and understanding the diseases, we urge the examination of human liver tissue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.